PB1872: SELINEXOR IN COMBINATION WITH VENETOCLAX AND HYPOMETHYLATING AGENTS FOR ACUTE MYELOID LEUKEMIA PATIENTS WITH SEVERE CO-MORBIDITIES

• Fangli Chen,
• Limin Zhao,
• Yuanmei Zhai,
• Lili Pei,
• Tinghua Zhang,
• Zhizhi Zhang,
• Yingting Lu,
• Beibei Qu,
• Jing Zhang,
• Xuewei Jiang,
• LI Yang,
• Ligen Liu

Affiliations

Fangli Chen

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Limin Zhao

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Yuanmei Zhai

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Lili Pei

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Tinghua Zhang

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Zhizhi Zhang

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Yingting Lu

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Beibei Qu

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Jing Zhang

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Xuewei Jiang

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

LI Yang

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China

Ligen Liu

1 Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Department of Hematology, Shanghai, China